keyword
MENU ▼
Read by QxMD icon Read
search

Aspirin AND Cancer

keyword
https://www.readbyqxmd.com/read/30221595/effect-of-aspirin-on-all-cause-mortality-in-the-healthy-elderly
#1
John J McNeil, Mark R Nelson, Robyn L Woods, Jessica E Lockery, Rory Wolfe, Christopher M Reid, Brenda Kirpach, Raj C Shah, Diane G Ives, Elsdon Storey, Joanne Ryan, Andrew M Tonkin, Anne B Newman, Jeff D Williamson, Karen L Margolis, Michael E Ernst, Walter P Abhayaratna, Nigel Stocks, Sharyn M Fitzgerald, Suzanne G Orchard, Ruth E Trevaks, Lawrence J Beilin, Geoffrey A Donnan, Peter Gibbs, Colin I Johnston, Barbara Radziszewska, Richard Grimm, Anne M Murray
Background In the primary analysis of the Aspirin in Reducing Events in the Elderly (ASPREE) trial, now published in the Journal, we report that the daily use of aspirin did not provide a benefit with regard to the primary end point of disability-free survival among older adults. A numerically higher rate of the secondary end point of death from any cause was observed with aspirin than with placebo. Methods From 2010 through 2014, we enrolled community-dwelling persons in Australia and the United States who were 70 years of age or older (or ≥65 years of age among blacks and Hispanics in the United States) and did not have cardiovascular disease, dementia, or disability...
September 16, 2018: New England Journal of Medicine
https://www.readbyqxmd.com/read/30220322/protective-effects-of-metformin-statins-and-anti-inflammatory-drugs-on-head-and-neck-cancer-a-systematic-review
#2
REVIEW
Constanza Saka Herrán, Enric Jané-Salas, Albert Estrugo Devesa, José López-López
The main objective of this study was to evaluate the effect of metformin, statins and anti-inflammatory drugs (NSAIDs) on head and neck cancer (HNC). Specifically, the potential beneficial effects on risk, survival and recurrence based on epidemiological studies. PRISMA guidelines were followed. After searching MEDLINE (PubMed), IBECS, LILACS and the Cochrane Central Register for Controlled Trials, 13 studies met the inclusion criteria and so underwent qualitative synthesis (six studies for metformin and seven for NSAIDs)...
October 2018: Oral Oncology
https://www.readbyqxmd.com/read/30214631/aspirin-cooperates-with-p300-to-activate-the-acetylation-of-h3k9-and-promote-fasl-mediated-apoptosis-of-cancer-stem-like-cells-in-colorectal-cancer
#3
Zhigang Chen, Wenlu Li, Fuming Qiu, Qi Huang, Zhou Jiang, Jun Ye, Pu Cheng, Cho Low, Yikun Guo, Xinchi Yi, Wenteng Chen, Yongpin Yu, YueHua Han, Jun Wu, Shenghang Jin, Dong Kong, Jian Huang
Cancer stem-like cells (CSCs) have been proposed as a key driving force of tumor growth and relapse in colorectal cancer (CRC), and therefore, they are promising targets for cancer therapy. Epidemiological evidence has suggested that the daily use of aspirin reduces overall mortality of CRC and the risk of distant metastasis. We investigated the effect and mechanism of aspirin on CSCs in CRC. Methods: The ratio of CSCs was analyzed after aspirin treatment both in a cell model and patient samples. Chemically modified aspirin and immunoprecipitation were adopted to detect the target proteins of aspirin...
2018: Theranostics
https://www.readbyqxmd.com/read/30191523/ketoconazole-plus-lenalidomide-in-patients-with-castration-resistant-prostate-cancer-crpc-results-of-an-open-label-phase-ii-study
#4
Pedro C Barata, Matthew Cooney, Prateek Mendiratta, Allison Tyler, Robert Dreicer, Jorge A Garcia
Introduction Ketoconazole is CYP-17 inhibitor with demonstrated activity in men with castration-resistant prostate cancer (CRPC). Lenalidomide is an antiangiogenic and immunomodulatory agent with broad antitumor activity. We hypothesized that the modulation of the cellular immune response to apoptosis caused by ketoconazole may be increased with the addition of lenalidomide. Methods This is an open-label, non-randomized, single-arm phase II study evaluating the efficacy and safety of the combination of ketoconazole and lenalidomide in patients with CRPC...
September 6, 2018: Investigational New Drugs
https://www.readbyqxmd.com/read/30188953/chronic-obstructive-pulmonary-disease-with-short-acting-inhaled-pharmacotherapy-increases-the-risk-of-prostate-cancer-a-two-stage-database-approach
#5
Hui-Wen Lin, Li-Fong Lin, Hung-Chou Chen, Tsan-Hon Liou, Shih-Wei Huang
BACKGROUND: Patients with chronic obstructive pulmonary disease (COPD) are at a higher risk of many types of cancer. However, specific investigation of the risk of prostate cancer and the influence of COPD pharmacotherapy in patients with COPD is lacking. This study investigated the risk and influence of COPD pharmacotherapy on risk of prostate cancer in patients with COPD. METHODS: This retrospective cohort study used data from Taiwan's Longitudinal Health Insurance Database 2005 (LHID2005)...
2018: PloS One
https://www.readbyqxmd.com/read/30183988/antiplatelet-therapy-in-breast-cancer-patients-using-hormonal-therapy-myths-evidence-and-potentialities-systematic-review
#6
Andréa de Melo Leite, Ariane Vieira Scarlatelli Macedo, Antonio José Lagoeiro Jorge, Wolney de Andrade Martins
Breast cancer is the most frequently diagnosed tumor in women worldwide, with a significant impact on morbidity and mortality. Chemotherapy and hormone therapy have significantly reduced mortality; however, the adverse effects are significant. Aspirin has been incorporated into clinical practice for over 100 years at a low cost, making it particularly attractive as a potential agent in breast cancer prevention and as an adjunct treatment to endocrine therapy in the prophylaxis of cardiovascular complications...
August 2018: Arquivos Brasileiros de Cardiologia
https://www.readbyqxmd.com/read/30180958/safety-of-diagnostic-and-therapeutic-cardiac-catheterization-in-cancer-patients-with-acute-coronary-syndrome-and-chronic-thrombocytopenia
#7
Cezar Iliescu, Dinu V Balanescu, Teodora Donisan, Dana E Giza, Ezequiel D Muñoz Gonzalez, Mehmet Cilingiroglu, Juhee Song, Siddharth S Mukerji, Juan C Lopez-Mattei, Peter Y Kim, Nicolas Palaskas, Elie N Mouhayar, Jean-Bernard Durand, Konstantinos Marmagkiolis
Little data is available on the bleeding risk and outcomes of cancer patients with chronic thrombocytopenia who underwent cardiac catheterization. We sought to assess the safety of coronary angiography, percutaneous coronary intervention, and antiplatelet therapy in cancer patients with acute coronary syndrome (ACS) and chronic thrombocytopenia. We performed a retrospective study of patients with chronic thrombocytopenia who underwent cardiac catheterization for ACS between November 2009 and November 2015. Preprocedural platelet counts were classified into 3 groups: mild thrombocytopenia (50,000 to 100,000/µL), moderate thrombocytopenia (30,000 to 50,000/µL), and severe thrombocytopenia (<30,000/µL)...
August 3, 2018: American Journal of Cardiology
https://www.readbyqxmd.com/read/30178690/antithrombotic-treatment-and-risk-of-complications-after-head-and-neck-full-thickness-skin-graft-surgery
#8
Martin Hasselgren, Thomas Runer, Peter Janson, Magnus Ekström
Head and neck skin cancer surgery using a full thickness skin graft is a common procedure. Evidence concerning the effects of perioperative antithrombotic treatment on complications is limited. The aim of this study was to evaluate whether perioperative antithrombotic treatment is associated with risk of necrosis, bleeding or infection after full thickness skin graft surgery. Retrospective single-center cohort study with medical records review. Patients operated with a head and neck full thickness skin graft in 2010 and 2013-2015 had available data and were included...
September 4, 2018: Journal of Plastic Surgery and Hand Surgery
https://www.readbyqxmd.com/read/30173426/-risk-factors-for-early-castration-resistant-prostate-cancer-after-androgen-deprivation-therapy-for-bone-metastatic-prostate-cancer
#9
Feng-Ming Huang, Xiao-Hong Li, Yong Liang
Objective: To investigate the risk factors for early castration-resistant prostate cancer (CRPC) after androgen deprivation therapy (ADT) in patients primarily diagnosed with bone-metastatic prostate cancer (BMPC). METHODS: We retrospectively analyzed the clinical data on 97 cases of primarily diagnosed BMPC treated in our hospital between January 2010 and May 2016. We included the patients without CRPC in group A and those with CRPC found within 12 months after ADT in group B...
August 2018: Zhonghua Nan Ke Xue, National Journal of Andrology
https://www.readbyqxmd.com/read/30171037/racial-and-ethnic-differences-in-the-relationship-between-aspirin-use-and-non-small-cell-lung-cancer-risk-and-survival
#10
Patricia Erickson, Lisa D Gardner, Christopher A Loffredo, Diane Marie St George, Elise D Bowman, Janaki Deepak, Khadijah A Mitchell, Claire L Meaney, Patricia Langenberg, Debra H Bernat, Sania Amr, Brid M Ryan
BACKGROUND: African Americans (AA) experience higher incidence and mortality of lung cancer as compared with European Americans (EA). Inflammation is associated with lung cancer, many aspects of which differ between AA and EA. We investigated whether use, frequency, and duration of the anti-inflammatory drug aspirin was associated with lung cancer risk and survival, separately among AA and EA populations. METHODS: Using data from the Maryland Non-Small Cell Lung Cancer (NSCLC) Case-Control Study (1,220 cases [404 AA and 816 EA] and 1,634 controls [1,004 EA and 630 AA]), we estimated the adjusted odds ratios (OR) and hazard ratios (HR) with 95% confidence intervals (CI) of the associations between aspirin use and NSCLC risk and survival, respectively...
August 31, 2018: Cancer Epidemiology, Biomarkers & Prevention
https://www.readbyqxmd.com/read/30159181/coexistent-breast-cancer-and-essential-thrombocythemia-how-we-addressed-the-therapeutic-challenges
#11
Karan Seegobin, Bharatsinh Gharia, Satish Maharaj, Lara Zuberi
Essential thrombocythemia (ET) occurring with breast cancer is uncommon; the therapeutic approach varies and poses a challenge. A 65-year-old female presented to us after being diagnosed with hormone positive, HER2-negative infiltrating ductal carcinoma. She had a platelet count of 600 thou/cu mm. Her JAK2 mutation was positive. Bone marrow biopsy showed increased megakaryocytes. She was diagnosed with ET in the setting of breast cancer. She underwent breast conservation surgery after which aspirin was resumed...
2018: Case Reports in Hematology
https://www.readbyqxmd.com/read/30153096/hydroxycarbamide-plus-aspirin-versus-aspirin-alone-in-patients-with-essential-thrombocythemia-age-40-to-59-years-without-high-risk-features
#12
Anna L Godfrey, Peter J Campbell, Cathy MacLean, Georgina Buck, Julia Cook, Julie Temple, Bridget S Wilkins, Keith Wheatley, Jyoti Nangalia, Jacob Grinfeld, Mary Frances McMullin, Cecily Forsyth, Jean-Jacques Kiladjian, Anthony R Green, Claire N Harrison
Purpose Cytoreductive therapy is beneficial in patients with essential thrombocythemia (ET) at high risk of thrombosis. However, its value in those lacking high-risk features remains unknown. This open-label, randomized trial compared hydroxycarbamide plus aspirin with aspirin alone in patients with ET age 40 to 59 years and without high-risk factors or extreme thrombocytosis. Patients and Methods Patients were age 40 to 59 years and lacked a history of ischemia, thrombosis, embolism, hemorrhage, extreme thrombocytosis (platelet count ≥ 1,500 × 109 /L), hypertension, or diabetes requiring therapy...
August 28, 2018: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
https://www.readbyqxmd.com/read/30149897/unplanned-hospitalizations-in-a-racially-and-ethnically-diverse-population-of-women-receiving-chemotherapy-for-epithelial-ovarian-cancer
#13
Shayan Dioun, Jennifer R Jorgensen, Eirwen M Miller, Joan Tymon-Rosario, Xianhong Xie, Xiaonan Xue, Dennis Yi-Shin Kuo, Nicole S Nevadunsky
OBJECTIVES: Unplanned hospital admission following chemotherapy is a measure of quality cancer care. Large retrospective datasets have shown admission rates of 10-35% for women with ovarian cancer receiving chemotherapy. We sought to evaluate the prevalence and associated risk factors for hospital admission following chemotherapy in our racially diverse urban population. METHODS: After IRB approval, clinicopathologic and treatment data were abstracted from all patients with newly diagnosed epithelial ovarian cancer who received chemotherapy at our institution from 2005 to 2016...
August 24, 2018: Gynecologic Oncology
https://www.readbyqxmd.com/read/30149368/pharmacological-and-dietary-factors-in-prevention-of-colorectal-cancer
#14
M Waluga, M Zorniak, J Fichna, M Kukla, M Hartleb
Colorectal cancer (CRC) is the third most prevalent neoplasm worldwide and fourth most frequent reason of cancer-related death throughout the world. About 70% of malignant tumors are related to lifestyle and environmental factors, and better knowledge of their significance might reduce the prevalence of CRC. The cyclooxygenase-2 (COX-2) inhibitory and other direct and indirect pathways of aspirin are translated to inhibition proliferation and enhanced apoptosis of cancer cells. Many studies showed the benefits of aspirin in reducing the risk of CRC development, cancer-related mortality and adenoma prevalence rate in general population, but not in high risk populations...
June 2018: Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society
https://www.readbyqxmd.com/read/30148827/chemoprevention-of-colorectal-cancer-aspirin-and-beyond
#15
Paul J Limburg
No abstract text is available yet for this article.
August 2018: Clinical Advances in Hematology & Oncology: H&O
https://www.readbyqxmd.com/read/30146931/effects-of-aspirin-for-primary-prevention-in-persons-with-diabetes-mellitus
#16
(no author information available yet)
Background Diabetes mellitus is associated with an increased risk of cardiovascular events. Aspirin use reduces the risk of occlusive vascular events but increases the risk of bleeding; the balance of benefits and hazards for the prevention of first cardiovascular events in patients with diabetes is unclear. Methods We randomly assigned adults who had diabetes but no evident cardiovascular disease to receive aspirin at a dose of 100 mg daily or matching placebo. The primary efficacy outcome was the first serious vascular event (i...
August 26, 2018: New England Journal of Medicine
https://www.readbyqxmd.com/read/30144594/aspirin-affects-tumor-angiogenesis-and-sensitizes-human-glioblastoma-endothelial-cells-to-temozolomide-bevacizumab-and-sunitinib-impairing-vascular-endothelial-growth-factor-related-signaling
#17
Stefania Elena Navone, Laura Guarnaccia, Chiara Cordiglieri, Francesco Maria Crisà, Manuela Caroli, Marco Locatelli, Luigi Schisano, Paolo Rampini, Monica Miozzo, Nicla La Verde, Laura Riboni, Rolando Campanella, Giovanni Marfia
BACKGROUND: Glioblastoma (GBM) is the most common and fatal human brain tumor, with the worst prognosis. The aberrant microenvironment, enhanced by the activation of proangiogenic mediators such as hypoxia-inducible factor-1α (HIF-1α), vascular endothelial growth factor (VEGF), and their downstream effectors, sustain GBM malignancy. Proangiogenic signaling represents an attractive chemotherapeutic target. Recent evidence suggests a therapeutic benefit from aspirin (acetylsalicylic acid, or ASA) intake in reducing risk and cancer progression...
August 23, 2018: World Neurosurgery
https://www.readbyqxmd.com/read/30139291/a-case-report-of-cangrelor-bridge-therapy-for-a-diagnostic-bronchoscopy-with-biopsy
#18
Matthew W Calnan, Alexis N Crawford
Although premature discontinuation of dual antiplatelet therapy (DAPT) is associated with an increased risk of ischemic complications, patients may present with an urgent need for surgery that would require interruption of DAPT. Antiplatelet bridge therapy using cangrelor, an intravenous P2Y12 inhibitor, has been studied as a potential option to ensure continuation of DAPT perioperatively. However, limited evidence exists supporting the off-label use of cangrelor bridge therapy to noncardiac procedures. We describe the case of a 67-year-old class 3 obese female on DAPT (aspirin and ticagrelor) for recent drug-eluting stent placement who required a bronchoscopy with biopsy for suspected lung cancer...
August 23, 2018: Journal of Pharmacy Practice
https://www.readbyqxmd.com/read/30133455/aspirin-associated-with-risk-reduction-of-secondary-primary-cancer-for-patients-with-head-and-neck-cancer-a-population-based-analysis
#19
Yu-Shan Lin, Chih-Ching Yeh, Shiang-Fu Huang, Yi-Sheng Chou, Li-Tang Kuo, Fung-Chang Sung, Chih-Hsin Muo, Chien-Tien Su, Fu-Hsiung Su
As reported by the Taiwan Cancer Registry in 2013 squamous cell carcinoma of head and neck cancer (HNSCC) was the sixth most frequently diagnosed cancer and the 5th most common cause of cancer related death and its incidence and mortality rate is still rising. The co-occurrence of HNSCC and secondary primary cancer (SPC) and the chemopreventive effect of aspirin on certain malignancies had been reported. Therefore we conducted this national study to investigate the use of aspirin associated with risk reduction of secondary primary cancer for patients with head and neck cancer in Taiwan...
2018: PloS One
https://www.readbyqxmd.com/read/30131302/disruption-of-chromosomal-architecture-of-cox2-locus-sensitizes-lung-cancer-cells-to-radiotherapy
#20
Yuxiang Sun, Hui Dai, Shaopeng Chen, Yajun Zhang, Tao Wu, Xianbin Cao, Guoping Zhao, An Xu, Jun Wang, Lijun Wu
Despite treatment of lung cancer with radiotherapy and chemotherapy, the survival rate of lung cancer patients remains poor. Previous studies demonstrated the importance of upregulation of inflammatory factors, such as cyclooxygenase 2 (cox2), in tumor tolerance. In the present study, we investigated the role of cox2 in radiosensitivity of lung cancer. Our results showed that the combination treatment of radiation with aspirin, an anti-inflammatory drug, induced a synergistic reduction of cell survival in A549 and H1299 lung cancer cells...
August 8, 2018: Molecular Therapy: the Journal of the American Society of Gene Therapy
keyword
keyword
110476
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"